Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
000877.SZ Stock Summary
In the News
000877.SZ Financial details
Company Rating
Strong Buy
Market Cap
57.1B
Income
1.78B
Revenue
106.75B
Book val./share
9.71
Cash/share
1.81
Dividend
0.27
Dividend %
4.22%
Employees
61.66K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
98.87
Forward P/E
-
PEG
-16.56
P/S
0.48
P/B
0.69
P/C
3.72
P/FCF
-25.65
Quick Ratio
0.5
Current Ratio
0.59
Debt / Equity
1.68
LT Debt / Equity
0.67
-
-
EPS (TTM)
0.21
EPS next Y
-
EPS next Q
-
EPS this Y
-55.77%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-31.81%
Revenue last 5Y
61.04%
Revenue Q/Q
-2.17%
EPS Q/Q
-2195.24%
-
-
-
-
SMA20
-
SMA50
16.67%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
1%
ROC
-
Gross Margin
15%
Oper. Margin
-
Profit Margin
-
Payout
1132%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.99-9.27
52W High
-25.11%
52W Low
+34.8%
RSI
49
Rel Volume
0.67
Avg Volume
13.37M
Volume
8.98M
Perf Week
-0.59%
Perf Month
0%
Perf Quarter
-4.53%
Perf Half Y
-9.41%
-
-
-
-
Beta
0.769
-
-
Volatility
0.08%, 0.14%
Prev Close
0.15%
Price
6.74
Change
-0.88%
000877.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 9.24 | 8.29 | 20.36 | 15.3 | 12.11 | |
Net income per share | 1.56 | 1.45 | 1.5 | 0.52 | 0.23 | |
Operating cash flow per share | 2.55 | 2.45 | 3.4 | 1.76 | 2 | |
Free cash flow per share | 2.39 | 2.33 | 1.01 | -0.03 | 0.77 | |
Cash per share | 0.8 | 1.21 | 1.84 | 1.35 | 1.81 | |
Book value per share | 9.2 | 10.14 | 9.1 | 9.44 | 9.71 | |
Tangible book value per share | 9 | 10.17 | 3.48 | 3.67 | 4.01 | |
Share holders equity per share | 9.2 | 10.14 | 9.1 | 9.44 | 9.71 | |
Interest debt per share | 2.64 | 0.83 | 10.51 | 11.33 | 16.79 | |
Market cap | 12.43B | 15.84B | 127.82B | 73.81B | 56.66B | |
Enterprise value | 14.29B | 15.45B | 196.38B | 156.47B | 185.88B | |
P/E ratio | 7.6 | 10.44 | 10.19 | 16.25 | 28.83 | |
Price to sales ratio | 1.28 | 1.82 | 0.75 | 0.56 | 0.54 | |
POCF ratio | 4.64 | 6.17 | 4.5 | 4.84 | 3.28 | |
PFCF ratio | 4.97 | 6.49 | 15.21 | -271.33 | 8.54 | |
P/B Ratio | 1.29 | 1.49 | 1.68 | 0.9 | 0.67 | |
PTB ratio | 1.29 | 1.49 | 1.68 | 0.9 | 0.67 | |
EV to sales | 1.48 | 1.78 | 1.16 | 1.18 | 1.77 | |
Enterprise value over EBITDA | 4.24 | 4.8 | 4.89 | 7.93 | 12.02 | |
EV to operating cash flow | 5.34 | 6.02 | 6.91 | 10.26 | 10.74 | |
EV to free cash flow | 5.71 | 6.33 | 23.38 | -575.18 | 28.01 | |
Earnings yield | 0.13 | 0.1 | 0.1 | 0.06 | 0.03 | |
Free cash flow yield | 0.2 | 0.15 | 0.07 | 0 | 0.12 | |
Debt to equity | 0.26 | 0.07 | 1.09 | 1.14 | 1.68 | |
Debt to assets | 0.17 | 0.05 | 0.29 | 0.32 | 0.48 | |
Net debt to EBITDA | 0.55 | -0.12 | 1.71 | 4.19 | 8.35 | |
Current ratio | 0.89 | 1.34 | 0.52 | 0.51 | 0.56 | |
Interest coverage | 11.4 | 20.67 | 6.29 | 2.04 | 1.14 | |
Income quality | 1.46 | 1.49 | 1.9 | 3.01 | 8.8 | |
Dividend Yield | 0.05 | 0.04 | 0.1 | 0.21 | 0.1 | |
Payout ratio | 0.36 | 0.41 | 1.04 | 3.38 | 2.84 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | |
Research and developement to revenue | 0 | 0.01 | 0.01 | 0.01 | 0.02 | |
Intangibles to total assets | 0.05 | 0.04 | 0.22 | 0.23 | 0.23 | |
Capex to operating cash flow | -0.07 | -0.05 | -0.7 | -1.02 | -0.62 | |
Capex to revenue | -0.02 | -0.01 | -0.12 | -0.12 | -0.1 | |
Capex to depreciation | -0.21 | -0.16 | -2.15 | -1.55 | -0.97 | |
Stock based compensation to revenue | 0 | 0.07 | 0 | 0.01 | -0.2 | |
Graham number | 17.97 | 18.16 | 17.54 | 10.55 | 7.04 | |
ROIC | 0.15 | 0.12 | 0.14 | 0.04 | 0.01 | |
Return on tangible assets | 0.11 | 0.11 | 0.06 | 0.02 | 0.01 | |
Graham Net | -2.63 | -0.82 | -16.6 | -16.39 | -16.59 | |
Working capital | -365.32M | 870.27M | -66.96B | -66.24B | -50.78B | |
Tangible asset value | 9.44B | 10.66B | 29.04B | 31.76B | 34.75B | |
Net current asset value | -2.1B | -199.87M | -120.58B | -123.6B | -127.55B | |
Invested capital | 0.26 | 0.07 | 1.09 | 1.14 | 1.68 | |
Average receivables | 1.88B | 1.8B | 24.04B | 44.48B | 40.94B | |
Average payables | 1.16B | 1.25B | 19.27B | 39.15B | 35.49B | |
Average inventory | 356.1M | 373.78M | 5.23B | 10.91B | 10.56B | |
Days sales outstanding | 68.44 | 74.62 | 99.45 | 117.39 | 136.46 | |
Days payables outstanding | 67.72 | 91.15 | 106.38 | 134.87 | 118.25 | |
Days of inventory on hand | 20.85 | 26.55 | 28.78 | 38.58 | 37.08 | |
Receivables turnover | 5.33 | 4.89 | 3.67 | 3.11 | 2.67 | |
Payables turnover | 5.39 | 4 | 3.43 | 2.71 | 3.09 | |
Inventory turnover | 17.5 | 13.75 | 12.68 | 9.46 | 9.84 | |
ROE | 0.17 | 0.14 | 0.17 | 0.06 | 0.02 | |
Capex per share | -0.17 | -0.12 | -2.4 | -1.79 | -1.23 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.92 | 2.58 | 3.59 | 3.11 | 3.04 | |
Net income per share | 0.08 | -0.16 | 0.16 | -0.01 | 0.22 | |
Operating cash flow per share | 0.08 | -0.16 | 0.83 | 0.29 | 0.69 | |
Free cash flow per share | -0.35 | -0.62 | 0.7 | 0.02 | 0.31 | |
Cash per share | 1.35 | 2.1 | 1.98 | 2.26 | 1.81 | |
Book value per share | 9.44 | 9.32 | 9.2 | 9.2 | 9.71 | |
Tangible book value per share | 3.67 | 3.51 | 3.26 | 3.31 | 4.01 | |
Share holders equity per share | 9.44 | 9.32 | 9.2 | 9.2 | 9.71 | |
Interest debt per share | 10.93 | 12.06 | 12.62 | 13.03 | 16.45 | |
Market cap | 73.81B | 76.76B | 70.52B | 67.4B | 56.66B | |
Enterprise value | 156.47B | 163.03B | 162.94B | 160.88B | 185.88B | |
P/E ratio | 26.96 | -13.6 | 12.84 | -185.37 | 7.4 | |
Price to sales ratio | 2.17 | 3.43 | 2.27 | 2.5 | 2.15 | |
POCF ratio | 107.82 | -54.38 | 9.86 | 26.96 | 9.51 | |
PFCF ratio | -24.44 | -14.38 | 11.65 | 432.83 | 21.31 | |
P/B Ratio | 0.9 | 0.95 | 0.88 | 0.85 | 0.67 | |
PTB ratio | 0.9 | 0.95 | 0.88 | 0.85 | 0.67 | |
EV to sales | 4.61 | 7.29 | 5.25 | 5.97 | 7.05 | |
Enterprise value over EBITDA | 154.09 | -375.68 | 55.17 | 248.06 | 36.56 | |
EV to operating cash flow | 228.56 | -115.51 | 22.79 | 64.34 | 31.21 | |
EV to free cash flow | -51.81 | -30.55 | 26.92 | 1.03K | 69.9 | |
Earnings yield | 0.01 | -0.02 | 0.02 | 0 | 0.03 | |
Free cash flow yield | -0.04 | -0.07 | 0.09 | 0 | 0.05 | |
Debt to equity | 1.14 | 1.28 | 1.36 | 1.41 | 1.68 | |
Debt to assets | 0.32 | 0.35 | 0.37 | 0.37 | 0.48 | |
Net debt to EBITDA | 81.4 | -198.81 | 31.29 | 144.14 | 25.42 | |
Current ratio | 0.51 | 0.56 | 0.56 | 0.59 | 0.56 | |
Interest coverage | 0.03 | -1.34 | 1.88 | -0.34 | 2.48 | |
Income quality | 1 | 1 | 5.21 | -27.51 | 3.11 | |
Dividend Yield | 0.01 | 0.01 | 0.05 | 0.01 | 0 | |
Payout ratio | 1.29 | -0.77 | 2.53 | -9.27 | 0.09 | |
Sales general and administrative to revenue | -0.09 | 0.08 | -0.03 | 0.17 | -0.13 | |
Research and developement to revenue | 0.02 | 0.01 | 0.02 | 0.03 | 0.03 | |
Intangibles to total assets | 0.23 | 0.22 | 0.23 | 0.22 | 0.23 | |
Capex to operating cash flow | -5.41 | 2.78 | -0.15 | -0.94 | -0.55 | |
Capex to revenue | -0.11 | -0.18 | -0.04 | -0.09 | -0.13 | |
Capex to depreciation | -1.25 | -1.41 | -0.39 | 0.46 | -1.23 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 4.1 | 5.84 | 5.73 | 1.47 | 6.95 | |
ROIC | 0 | -0.01 | 0.01 | 0 | 0.01 | |
Return on tangible assets | 0 | -0.01 | 0.01 | 0 | 0.01 | |
Graham Net | -16.39 | -16.58 | -16.91 | -17 | -16.59 | |
Working capital | -66.24B | -58.07B | -56.19B | -52.07B | -50.78B | |
Tangible asset value | 31.76B | 30.43B | 28.26B | 28.7B | 34.75B | |
Net current asset value | -123.6B | -125.38B | -128.81B | -130B | -127.55B | |
Invested capital | 1.14 | 1.28 | 1.36 | 1.41 | 1.68 | |
Average receivables | 46.25B | 43.31B | 43.2B | 43.53B | 41.93B | |
Average payables | 40.59B | 41.09B | 41.46B | 41.08B | 35.07B | |
Average inventory | 12.11B | 11.66B | 11.07B | 10.09B | 9.48B | |
Days sales outstanding | 112.96 | 176.89 | 122.91 | 149.1 | 133.95 | |
Days payables outstanding | 127.24 | 184.14 | 148.85 | 158.53 | 120.67 | |
Days of inventory on hand | 36.4 | 51.85 | 37.6 | 37.77 | 37.84 | |
Receivables turnover | 0.8 | 0.51 | 0.73 | 0.6 | 0.67 | |
Payables turnover | 0.71 | 0.49 | 0.6 | 0.57 | 0.75 | |
Inventory turnover | 2.47 | 1.74 | 2.39 | 2.38 | 2.38 | |
ROE | 0.01 | -0.02 | 0.02 | 0 | 0.02 | |
Capex per share | -0.43 | -0.45 | -0.13 | -0.27 | -0.38 |
000877.SZ Frequently Asked Questions
What is Xinjiang Tianshan Cement Co., Ltd. stock symbol ?
Xinjiang Tianshan Cement Co., Ltd. is a CN stock and trading under the symbol 000877.SZ
What is Xinjiang Tianshan Cement Co., Ltd. stock quote today ?
Xinjiang Tianshan Cement Co., Ltd. stock price is $6.74 today.
Is Xinjiang Tianshan Cement Co., Ltd. stock public?
Yes, Xinjiang Tianshan Cement Co., Ltd. is a publicly traded company.